The CPCDI aims to increase the number of clinical trials conducted in Africa and to improve access to cutting-edge treatments for patients in the region by leveraging various industry partner and stakeholder’s strengths and facilitate the coordination of joint and prioritised activities to achieve its objectives of:
The Cross Pharma Capacity Development Initiative (CPCDI) is being implemented by the SFA Foundation with funding support from Janssen Pharmaceuticals.
CPCDI aims to increase clinical research and trial investments on the continent by drawing together local and sector partners to collectively develop clinical trial capacity and sustainably bring more trials to Africa.
Artificial intelligence (AI) and Data Science policy gaps from an African perspective. The African STI landscape is witnessing the emergence of AI and Data Science across various sectors. However, for these technologies to have their full positive impact, it is crucial to develop trust among stakeholders and formulate contextualized policies that support their implementation in the region. This grant aims to address these areas by:
" If scientific results are not shared broadly, then the societal benefits are significantly limited. We have a responsibility to ensure that policymakers have access to the best, relevant and up-to-date knowledge available. To achieve Africa’s sustainable development goals, it is critical that policy decisions are informed by contextually relevant evidence”. - Uzma Alam, SPEAR programme lead.